Schizophrenia study: Befriending
Official title Outcomes From Remediation and Behavioural Intervention Techniques
ClinicalTrials.gov ID: NCT05731414
What this study is testing
- What it's testing
- The study aims to discover which factors indicate whether a person will benefit from cognitive behavioural therapy for psychosis, cognitive remediation therapy, or a combination of both.
- Who it's for
- Adults diagnosed with schizophrenia‑spectrum or other psychotic disorders.
- What's involved
- Participants will receive either cognitive behavioural therapy for psychosis, cognitive remediation therapy, or both, and their progress will be measured.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Aged 18-65 years
- Diagnosed with schizophrenia-spectrum disorders
- Can read, write, and speak English
You likely can't join if
- Neurodevelopmental disability or neurocognitive disorder
- CBT or CR in the past 6 months
The study team makes the final eligibility decision.
Where it is enrolling
- Scarborough Village, Ontario, Canada
- Whitby, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Scarborough Village, Ontario, Canada; Whitby, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.